TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD.
Ching-Chieh ChouYi ZhangMfon E UmohSpencer W VaughanIleana LorenziniFeilin LiuMelissa SayeghPaul G Donlin-AspYu Han ChenDuc M DuongNicholas T SeyfriedMaureen A PowersThomas KukarChadwick M HalesMarla GearingNigel J CairnsKevin B BoylanGourisankar GhoshRosa RademakersYong-Jie ZhangLeonard PetrucelliRita SattlerDaniela C ZarnescuJonathan D GlassWilfried RossollPublished in: Nature neuroscience (2018)
The cytoplasmic mislocalization and aggregation of TAR DNA-binding protein-43 (TDP-43) is a common histopathological hallmark of the amyotrophic lateral sclerosis and frontotemporal dementia disease spectrum (ALS/FTD). However, the composition of aggregates and their contribution to the disease process remain unknown. Here we used proximity-dependent biotin identification (BioID) to interrogate the interactome of detergent-insoluble TDP-43 aggregates and found them enriched for components of the nuclear pore complex and nucleocytoplasmic transport machinery. Aggregated and disease-linked mutant TDP-43 triggered the sequestration and/or mislocalization of nucleoporins and transport factors, and interfered with nuclear protein import and RNA export in mouse primary cortical neurons, human fibroblasts and induced pluripotent stem cell-derived neurons. Nuclear pore pathology is present in brain tissue in cases of sporadic ALS and those involving genetic mutations in TARDBP and C9orf72. Our data strongly implicate TDP-43-mediated nucleocytoplasmic transport defects as a common disease mechanism in ALS/FTD.